ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
0.3519
+0.0167 (4.98%)
Apr 25, 2025, 10:48 AM EDT - Market open
ProPhase Labs Revenue
In the year 2024, ProPhase Labs had annual revenue of $6.77M, down -80.65%.
Revenue (ttm)
$6.77M
Revenue Growth
-80.65%
P/S Ratio
1.01
Revenue / Employee
$70,521
Employees
96
Market Cap
14.74M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 6.77M | -28.21M | -80.65% |
| Dec 31, 2023 | 34.98M | -87.66M | -71.48% |
| Dec 31, 2022 | 122.65M | 43.61M | 55.17% |
| Dec 31, 2021 | 79.04M | 64.53M | 444.59% |
| Dec 31, 2020 | 14.51M | 4.64M | 46.96% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 56.33B |
| AstraZeneca | 54.07B |
| Novartis AG | 51.72B |
| Eli Lilly and Company | 45.04B |
| Thermo Fisher Scientific | 42.90B |
PRPH News
- 24 days ago - ProPhase Labs, Inc. (PRPH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 25 days ago - ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024 - GlobeNewsWire
- 4 weeks ago - ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025 - GlobeNewsWire
- 7 weeks ago - ProPhase Labs to Present at the Investor Summit Virtual on March 11 - GlobeNewsWire
- 2 months ago - Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH) - GlobeNewsWire
- 2 months ago - ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs - GlobeNewsWire
- 2 months ago - ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables - GlobeNewsWire
- 2 months ago - ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports - GlobeNewsWire